Mog et al. developed a β2-GPI CATCR for anti-phospholipid syndrome (APS), an autoimmune blood clotting disorder characterized by autoantibodies against beta-2-glycoprotein I (β2-GPI). The gene discussed is APOH; the disease is antiphospholipid syndrome.